Shanghai Yizhong Pharmaceutical Co. Ltd. Class ASSE: 688091

"Shanghai Yizhong Pharmaceutical Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

Aug 29, 2026 · Issued by Shanghai Yizhong Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Shanghai Yizhong Pharmaceutical Co. Ltd. Class A

"Shanghai Yizhong Pharmaceutical Co., Ltd."Announcement on the Grant of Reserved Restricted Shares to Participants under the 2026 Restricted Share Incentive PlanAug 26
"Shanghai Yizhong Pharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial for the Investigational Innovative Drug YXC-002Aug 19
"Shanghai Yizhong Pharmaceutical Co., Ltd."Voluntary Disclosure Announcement on Receipt of a Notice of Approval for Drug Clinical Trial for the Investigational Innovative Drug YXC-001Aug 18
"Shanghai Yizhong Pharmaceutical Co., Ltd."Announcement on the Company and Its Wholly-owned Subsidiaries Using Certain Idle Raised Funds for Cash ManagementAug 7

All Shanghai Yizhong Pharmaceutical Co. Ltd. Class A news releases